德孚在中国

9 5 7 4 9

论文已发表

提 交 论 文


注册即可获取德孚的最新动态

注 册



IF 收录期刊





更多详情 >>





已发表论文

HOXA11-AS : 一种新型的人类癌症增殖和转移调节因子

 

Authors Xue JY, Huang C, Wang W, Li HB, Sun Ming, Xie M

Received 1 March 2018

Accepted for publication 1 June 2018

Published 27 July 2018 Volume 2018:11 Pages 4387—4393

DOI https://doi.org/10.2147/OTT.S166961

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Cristina Weinberg

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Geoffrey Pietersz

Abstract: Multiple studies have demonstrated that lncRNAs extensively participate in human cancer proliferation and metastasis. Epigenetic modification, transcriptional and posttranscriptional regulatory mechanisms are involved in lncRNA-led tumorigenesis and transfer. Recently, a novel identified homeobox (HOX) A11 antisense lncRNA, HOXA11-AS , 1,628 bp in length, has been excessively highlighted to be an essential initiator and facilitator in the process of malignant tumor proliferation and metastasis. As found in many reports, HOXA11-AS  can not only act as a molecular scaffold of PRC2, LSD1 and DNMT1 to epigenetically modify chromosomes in the nucleus but also occur as ceRNA competitively sponging miRNAs in the cytoplasm. Furthermore, HOXA11-AS  may function as a potential biomarker for cancer diagnosis and prognosis. In this review, we summarize the evolvement and mechanisms of HOXA11-AS  in proliferation and metastasis of various human cancers.
Keywords: HOXA11-AS , proliferation, metastasis, EMT, ceRNA, lncRNA, molecular scaffold

Table 1 HOXA11-AS expression levels are associated with clinicopathologic features


Download Article[PDF]